Publications

Development of an RNA aptamer as a therapeutic agent for synucleinopathies

 53
Development of an RNA aptamer as a therapeutic agent for synucleinopathies

Tags:

Previous Article

Cognitive symptoms in cerebral palsy from remote network

Next Article

RNA aptamer to treat synucleinopathies

Related Posts

Enteric neuroimmune interactions in health and disease

Enteric neuroimmune interactions in health and disease

 97

Redox regulation, protein S-nitrosylation, and synapse loss in Alzheimer’s and related dementias

Redox regulation, protein S-nitrosylation, and synapse ...

 195

A neurovascular survival axis for adult sympathetic neurons

A neurovascular survival axis for adult sympathetic neu...

 32